North America Menopause Market Size & Outlook, 2024-2030

The menopause market in North America is expected to reach a projected revenue of US$ 8,153.5 million by 2030. A compound annual growth rate of 4.5% is expected of North America menopause market from 2025 to 2030.
Revenue, 2024 (US$M)
$6,285.9
Forecast, 2030 (US$M)
$8,153.5
CAGR, 2025 - 2030
4.5%
Report Coverage
North America

North America menopause market highlights

  • The North America menopause market generated a revenue of USD 5,799.0 million in 2022.
  • The market is expected to grow at a CAGR of 4.4% from 2023 to 2030.
  • In terms of segment, dietary supplements was the largest revenue generating treatment in 2022.
  • Dietary Supplements is the most lucrative treatment segment registering the fastest growth during the forecast period.
  • Country-wise, U.S. is expected to register the highest CAGR from 2023 to 2030.


North America data book summary

Market revenue in 2022USD 5,799.0 million
Market revenue in 2030USD 8,153.5 million
Growth rate4.4% (CAGR from 2022 to 2030)
Largest segmentDietary supplements
Fastest growing segmentDietary Supplements
Historical data covered2018 - 2021
Base year for estimation2022
Forecast period covered2023 - 2030
Quantitative unitsRevenue in USD million
Market segmentationOTC pharma products, Dietary Supplements
Key market players worldwideBayer AG, AbbVie Inc, Abbott Laboratories, Nestle SA, Dr Reddy's Laboratories Ltd ADR, Theramex, Rainbow Light Nutritional Systems, Padagis


Other key industry trends

  • In terms of revenue, North America region accounted for 36.0% of the global menopause market in 2022.
  • Globally, Asia Pacific is projected to lead the regional market in terms of revenue in 2030.
  • Latin America is the fastest growing regional market and is projected to reach USD 1,618.6 million by 2030.

Dietary supplements was the largest segment with a revenue share of 94.32% in 2024. Horizon Databook has segmented the North America menopause market based on otc pharma products, dietary supplements covering the revenue growth of each sub-segment from 2018 to 2030.


The aging millennial population and growing prevalence of menopausal symptoms, such as hot flashes, are expected to drive the market in the region. Moreover, to cater to the increasing demand, ecommerce platforms and stores are providing dietary supplements targeted to ease menopausal symptoms. Significant adverse effects associated with HRT are leading to a decline in its adoption and a consequent increase in the adoption of dietary supplements.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Menopause Market Scope

Menopause market segmentation & scope
Hormonal
Non-Hormonal
Dietary Supplements
Countries
UK
Sweden
Norway
Denmark
Australia
Thailand
Argentina
Saudi Arabia
UAE
Kuwait

Menopause Market Companies

Name Profile # Employees HQ Website

North America menopause market size, by country, 2018-2030 (US$M)

North America Menopause Market Outlook Share, 2024 & 2030 (US$M)

North America menopause market size, by country, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more